Cargando…
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
Myotonic dystrophy type I (DM1) is the most common form of adult muscular dystrophy, caused by expansion of a CTG triplet repeat in the 3′ untranslated region (3′UTR) of the myotonic dystrophy protein kinase (DMPK) gene. The pathological CTG repeats result in protein trapping by expanded transcripts...
Autores principales: | López-Martínez, Andrea, Soblechero-Martín, Patricia, de-la-Puente-Ovejero, Laura, Nogales-Gadea, Gisela, Arechavala-Gomeza, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564762/ https://www.ncbi.nlm.nih.gov/pubmed/32971903 http://dx.doi.org/10.3390/genes11091109 |
Ejemplares similares
-
The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
por: Koehorst, Emma, et al.
Publicado: (2020) -
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
por: Soblechero‐Martín, Patricia, et al.
Publicado: (2021) -
Duchenne muscular dystrophy cell culture models created by CRISPR/Cas9 gene editing and their application in drug screening
por: Soblechero-Martín, Patricia, et al.
Publicado: (2021) -
An Overview of Circular RNAs and Their Implications in Myotonic Dystrophy
por: Czubak, Karol, et al.
Publicado: (2019) -
Splicing modulation therapy in the treatment of genetic diseases
por: Arechavala-Gomeza, Virginia, et al.
Publicado: (2014)